{"id":"https://openalex.org/W2397672408","doi":null,"title":"Cyclin-dependent kinase and protein kinase C inhibitors: a novel class of antineoplastic agents in clinical development.","display_name":"Cyclin-dependent kinase and protein kinase C inhibitors: a novel class of antineoplastic agents in clinical development.","publication_year":2000,"publication_date":"2000-07-01","ids":{"openalex":"https://openalex.org/W2397672408","mag":"2397672408","pmid":"https://pubmed.ncbi.nlm.nih.gov/11038138"},"language":"en","primary_location":{"id":"pmid:11038138","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11038138","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer journal (Sudbury, Mass.)","raw_type":"Journal Article"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001637416","display_name":"Andreas Kaubisch","orcid":"https://orcid.org/0000-0003-3410-664X","observed_orcids":["https://orcid.org/0000-0003-3410-664X"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A Kaubisch","raw_affiliation_strings":["Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5006913373","display_name":"Gary K. Schwartz","orcid":"https://orcid.org/0000-0003-1813-5061","observed_orcids":["https://orcid.org/0000-0003-1813-5061"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G K Schwartz","raw_affiliation_strings":["Memorial-Sloan Kettering Cancer Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial-Sloan Kettering Cancer Center","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1334819555"],"apc_list":null,"apc_paid":null,"fwci":2.9464,"has_fulltext":false,"cited_by_count":24,"citation_normalized_percentile":{"value":0.91403545,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":null,"biblio":{"volume":"6","issue":"4","first_page":"192","last_page":"212"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.7085000276565552,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.7085000276565552,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.14480000734329224,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.044599998742341995,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cyclin-dependent-kinase-inhibitors","display_name":"cyclin-dependent kinase inhibitors","score":0.9670000076293945},{"id":"https://openalex.org/keywords/protein-kinase-c-inhibitors","display_name":"PKC inhibitors","score":1.0},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.9190000295639038},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.8709999918937683},{"id":"https://openalex.org/keywords/chemotherapy-induced-apoptosis","display_name":"chemotherapy-induced apoptosis","score":0.722000002861023},{"id":"https://openalex.org/keywords/cell-cycle-arrest","display_name":"cell cycle arrest","score":0.9120000004768372},{"id":"https://openalex.org/keywords/kinase-inhibitors","display_name":"kinase inhibitors","score":0.6019999980926514},{"id":"https://openalex.org/keywords/cancer-therapy","display_name":"cancer therapy","score":0.4059999883174896},{"id":"https://openalex.org/keywords/clinical-trials","display_name":"clinical trials","score":0.6449999809265137},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.40299999713897705}],"concepts":[{"id":"https://openalex.org/C124320809","wikidata":"https://www.wikidata.org/wiki/Q46292","display_name":"Cyclin-dependent kinase","level":4,"score":0.8121153116226196},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.6295448541641235},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5353401899337769},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5297834873199463},{"id":"https://openalex.org/C195794163","wikidata":"https://www.wikidata.org/wiki/Q420877","display_name":"Protein kinase C","level":3,"score":0.5070044994354248},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.5024869441986084},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.49288153648376465},{"id":"https://openalex.org/C82495950","wikidata":"https://www.wikidata.org/wiki/Q14911732","display_name":"Cyclin-dependent kinase 2","level":4,"score":0.44212764501571655},{"id":"https://openalex.org/C51853150","wikidata":"https://www.wikidata.org/wiki/Q14911754","display_name":"Cyclin-dependent kinase 4","level":5,"score":0.43621039390563965},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.39442509412765503},{"id":"https://openalex.org/C97029542","wikidata":"https://www.wikidata.org/wiki/Q281417","display_name":"Protein kinase A","level":3,"score":0.3378356099128723},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.20627865195274353}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002453","descriptor_name":"Cell Cycle","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D011493","descriptor_name":"Protein Kinase C","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018844","descriptor_name":"Cyclin-Dependent Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:11038138","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11038138","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer journal (Sudbury, Mass.)","raw_type":"Journal Article"},{"id":"mag:2397672408","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11038138","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G7205842776","display_name":"Clinical Trials of Flavopiridol with Chemotherapy","funder_award_id":"R01CA067819","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W20014493","https://openalex.org/W2082855318","https://openalex.org/W2016586007","https://openalex.org/W1586091913","https://openalex.org/W7114808077","https://openalex.org/W1996578509","https://openalex.org/W1736381317","https://openalex.org/W2328600839","https://openalex.org/W4319304236","https://openalex.org/W2163207806"],"abstract_inverted_index":{"Malignant":[0],"cells":[1,27,48,162],"have":[2,235,260],"acquired":[3],"adaptations,":[4],"which":[5,259],"give":[6],"them":[7],"a":[8,66,79,84,105,186],"growth":[9],"and":[10,63,70,125,163,180,202,210,224,255],"survival":[11],"advantage":[12],"over":[13],"normal":[14,62],"cells.":[15],"One":[16],"effect":[17,128],"of":[18,20,46,52,90,98,102,108,129,138,144,168,174,177,207,220,249,253],"many":[19,25,188],"these":[21,221,232],"adaptations":[22],"is":[23,78],"that":[24,191],"cancerous":[26,64],"are":[28,39,49,135,153,198,228],"less":[29],"likely":[30],"to":[31,41,155,215],"undergo":[32],"programmed":[33],"cell":[34,59,119,145,157],"death":[35],"(apoptosis)":[36],"and,":[37],"moreover,":[38],"resistant":[40],"chemotherapy-induced":[42,169],"apoptosis.":[43,170],"Other":[44,132],"features":[45],"neoplastic":[47,161],"the":[50,58,88,96,127,142,195,230,244,247],"loss":[51],"regulated":[53],"or":[54],"orderly":[55],"progression":[56,147],"through":[57],"cycle.":[60],"In":[61,239],"cells,":[65],"balance":[67],"between":[68],"proapoptotic":[69],"antiapoptotic":[71,99],"signals":[72,92],"exists.":[73],"Protein":[74],"kinase":[75,82,133,189],"C":[76],"(PKC)":[77],"cellular":[80],"serine/threonine":[81],"with":[83],"central":[85],"role":[86,231],"in":[87,116,141,160,236,263],"mediation":[89],"mitogenic":[91],"as":[93,95,122,166,205],"well":[94],"regulation":[97],"signals.":[100],"Inhibition":[101],"PKC":[103,209],"by":[104,193],"novel":[106,251],"group":[107],"chemical":[109],"agents":[110,233,254],"(PKC":[111,179],"inhibitors)":[112],"can":[113],"induce":[114,156],"apoptosis":[115],"some":[117,219],"malignant":[118],"lines,":[120],"act":[121,165,192,204],"differentiating":[123],"agents,":[124],"enhance":[126],"cytotoxic":[130],"chemotherapy.":[131],"inhibitors":[134,137,152,190,206],"potent":[136],"kinases":[139,149,178],"involved":[140],"control":[143],"cycle":[146,158],"(cyclin-dependent":[148],"[cdks]).":[150],"Cdk":[151],"able":[154],"arrest":[159],"also":[164],"enhancers":[167],"The":[171],"catalytic":[172,196],"domain":[173],"different":[175],"classes":[176],"cdk)":[181],"share":[182],"considerable":[183],"homology.":[184],"As":[185],"result,":[187],"blocking":[194],"site":[197],"not":[199],"highly":[200],"specific":[201],"may":[203],"both":[208],"cdks.":[211],"Preclinical":[212],"studies":[213],"point":[214],"potential":[216],"applications":[217],"for":[218,246],"PKC/cdk":[222],"inhibitors,":[223],"current":[225],"clinical":[226,264],"trials":[227],"exploring":[229],"might":[234],"cancer":[237],"therapy.":[238],"this":[240,250],"article,":[241],"we":[242],"discuss":[243],"rationale":[245],"development":[248],"class":[252],"highlight":[256],"those":[257],"drugs,":[258],"shown":[261],"promise":[262],"testing.":[265]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}